![Thomas Fuchs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Fuchs
Directeur Technique/Scientifique/R&D chez
ELI LILLY AND COMPANY
Fortune : 97 192 $ au 31/08/2026
Profil
Thomas Fuchs is currently an Independent Director at GeneDx Holdings Corp.
since 2025.
Dr. Fuchs is also the Chief Artificial Intelligence Officer & Senior VP at Eli Lilly & Co. since 2024.
Dr. Fuchs holds a doctorate from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/09/2026 | 1 146 ( 0 % ) | 97 192 $ | 31/08/2026 |
Postes actifs de Thomas Fuchs
| Sociétés | Poste | Début |
|---|---|---|
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | 21/10/2024 |
| GENEDX HOLDINGS CORP. | Directeur/Membre du Conseil | 17/09/2025 |
Formation de Thomas Fuchs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graz University of Technology
 Graz University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx Holdings Corp.
 GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
